Trijn Israëls1, Elizabeth M Molyneux2. 1. VU University Medical Centre, Paediatric Haematology and Oncology-Outreach Program, De Boelelaan 1117, 1081 HV Amsterdam, Netherlands. 2. Department of Paediatrics, College of Medicine, Blantyre, Private Bag 360, Chichiri 3, Blantyre, Malawi.
Authors: Trijn Israels; Lorna Renner; Marc Hendricks; Peter Hesseling; Scott Howard; Elizabeth Molyneux Journal: Pediatr Blood Cancer Date: 2013-02-25 Impact factor: 3.167
Authors: Trijn Israels; Claude Moreira; Trish Scanlan; Liz Molyneux; Sam Kampondeni; Peter Hesseling; Hugo Heij; Eric Borgstein; Gordan Vujanic; Kathy Pritchard-Jones; Larry Hadley Journal: Pediatr Blood Cancer Date: 2012-09-26 Impact factor: 3.167
Authors: Trijn Israels; Eric Borgstein; Dalida Pidini; George Chagaluka; Jan de Kraker; Steve Kamiza; Elizabeth M Molyneux Journal: J Pediatr Hematol Oncol Date: 2012-11 Impact factor: 1.289
Authors: Dafalla O Abuidris; Mohammed E Elimam; Faisal M Nugud; Elgaili M Elgaili; Mohamed E Ahmed; Ramandeep S Arora Journal: Pediatr Blood Cancer Date: 2008-06 Impact factor: 3.167
Authors: Trijn Israëls; Joyce Kambugu; Francine Kouya; Nader Kim El-Mallawany; Peter B Hesseling; Gertjan J L Kaspers; Tim Eden; Lorna Renner; Elizabeth M Molyneux Journal: Nat Rev Clin Oncol Date: 2013-07-30 Impact factor: 66.675